Francisco J. Lopera

Cp 1226
Medellin, ANT, Colombia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 243 publications

Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer's disease.

Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer's disease.

Journal: Cell reports

Published: August 08, 2026

Astrocyte-driven small vessel disease is an early, amyloid-independent feature of PSEN1 E280A familial Alzheimer's disease.

Astrocyte-driven small vessel disease is an early, amyloid-independent feature of PSEN1 E280A familial Alzheimer's disease.

Journal: bioRxiv : the preprint server for biology

Published: August 01, 2026

Longevity and cognitive resilience in a Colombian family carrying the APOE ε2 variant.

Longevity and cognitive resilience in a Colombian family carrying the APOE ε2 variant.

Journal: Journal of Alzheimer's disease : JAD

Published: June 05, 2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Journal: Lancet (London, England)

Published: May 13, 2026

Circulating lipids uncover early membrane disruption as a primary event preceding Alzheimer's disease onset.

Circulating lipids uncover early membrane disruption as a primary event preceding Alzheimer's disease onset.

Journal: Research square

Published: May 07, 2026

Diversity-sensitive brain clocks linked to biophysical mechanisms in aging and dementia.

Diversity-sensitive brain clocks linked to biophysical mechanisms in aging and dementia.

Journal: Nature. Mental health

Published: April 03, 2026

Serum Lipidome as an Early Peripheral Indicator in Familial Alzheimer's Disease.

Serum Lipidome as an Early Peripheral Indicator in Familial Alzheimer's Disease.

Journal: bioRxiv : the preprint server for biology

Published: December 15, 2025

Upregulation of MAM by C99 disrupts ACSL4 activity and phospholipid homeostasis in Alzheimer's disease models.

Upregulation of MAM by C99 disrupts ACSL4 activity and phospholipid homeostasis in Alzheimer's disease models.

Journal: bioRxiv : the preprint server for biology

Published: December 15, 2025

Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial.

Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial.

Journal: EBioMedicine

Published: October 10, 2025

Comprehensive methodology for sample enrichment in EEG biomarker studies for Alzheimer's risk classification.

Comprehensive methodology for sample enrichment in EEG biomarker studies for Alzheimer's risk classification.

Journal: PloS one

Published: August 27, 2025

Genetic Contributions to Alzheimer's Disease and Frontotemporal Dementia in Admixed Latin American Populations.

Genetic Contributions to Alzheimer's Disease and Frontotemporal Dementia in Admixed Latin American Populations.

Journal: Research square

Published: May 19, 2025

Blood-based AT(N) biomarkers for Alzheimer's disease and frontotemporal lobar degeneration in Latin America.

Blood-based AT(N) biomarkers for Alzheimer's disease and frontotemporal lobar degeneration in Latin America.

Journal: Nature aging

Published: May 18, 2025

Showing 1-12 of 243

Last Updated: 09/26/2026